Pan Shu-Mei, Xing Chun-Yu, Li Hong-Wei, Wang Rui-Min, Pu Xin-Yue, Wang Tie-Gang, Wang Dan-Dan, Zou Li-Wei
Collaborative Innovation Center of Tumor Marker Detection Technology, Equipment and Diagnosis Therapy Integration in Universities of Shandong, Shandong Province Key Laboratory of Detection Technology for Tumor Makers, School of Chemistry and Chemical Engineering, Linyi University, Linyi 276005, China.
School of Materials Science and Engineering, North China University of Science and Technology, Tangshan 063210, Hebei, China.
J Anal Methods Chem. 2025 Jun 16;2025:1616740. doi: 10.1155/jamc/1616740. eCollection 2025.
Dipeptidyl peptidase IV (DPP IV), one of the most essential peptidase, is widely distributed in various organs and tissues of the human body, which affects protein stability by acting on peptide bonds at the end of peptide chains and is further involved in physiological processes such as cellular metabolism and signaling. Recent studies have shown that DPP IV is not only involved in normal physiological processes but also closely related to various pathological processes, making it an important target for the treatment of metabolic diseases. Deciphering the relevance of DPP IV to human diseases and screening the inhibitors of DPP IV requires reliable tools, which can sense the function of this key enzyme in complex biological samples. Therefore, we aimed to construct a simple and easy-to-use assay for human DPP IV activity in a living cell system to achieve highly sensitive and selective detection of DPP IV function and further screening for its inhibitors. An easy-to-use assay for DPP IV function at the cellular level with a specific fluorescence probe toward DPP IV using a fluorescence microplate reader was the first to be established. Then, the experimental conditions were systematically optimized in terms of cell density, concentrations of probe, and incubation time. After that, the efficacy of the positive DPP IV inhibitors was evaluated by utilizing the optimized easy-to-use assay. Overall, this easy-to-use assay exhibited good precision, robustness, high throughput, and reliability. In conclusion, a straightforward and user-friendly method has been developed for detecting DPP IV activity in live cells, enabling accurate assessment of DPP IV function and efficient screening of inhibitors. This method may hold significant implications for advancing understanding of the relationship between DPP IV and disease progression, early disease diagnosis, and personalized drug therapy.
二肽基肽酶IV(DPP IV)是最重要的肽酶之一,广泛分布于人体的各种器官和组织中,它通过作用于肽链末端的肽键来影响蛋白质稳定性,并进一步参与细胞代谢和信号传导等生理过程。最近的研究表明,DPP IV不仅参与正常生理过程,还与各种病理过程密切相关,使其成为治疗代谢性疾病的重要靶点。解读DPP IV与人类疾病的相关性并筛选DPP IV抑制剂需要可靠的工具,这些工具能够在复杂生物样品中感知这种关键酶的功能。因此,我们旨在构建一种简单易用的活细胞系统中人类DPP IV活性检测方法,以实现对DPP IV功能的高灵敏度和选择性检测,并进一步筛选其抑制剂。首先建立了一种在细胞水平上使用针对DPP IV的特异性荧光探针和荧光酶标仪检测DPP IV功能的易用方法。然后,从细胞密度、探针浓度和孵育时间等方面系统地优化了实验条件。之后,利用优化后的易用方法评估了阳性DPP IV抑制剂的效果。总体而言,这种易用方法具有良好的精密度、稳健性、高通量和可靠性。总之,已开发出一种直接且用户友好的方法来检测活细胞中的DPP IV活性,能够准确评估DPP IV功能并有效筛选抑制剂。该方法对于推进对DPP IV与疾病进展之间关系的理解、疾病早期诊断和个性化药物治疗可能具有重要意义。